Sandeep Kunwar Selected Research

IL13-PE38

1/2011	Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.
8/2010	Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
11/2007	Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
3/2007	Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.
4/2006	Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
2/2005	Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandeep Kunwar Research Topics

Disease

22	Neoplasms (Cancer) 01/2020 - 12/2002
8	Glioma (Gliomas) 01/2019 - 12/2002
7	Pituitary Neoplasms (Pituitary Adenoma) 01/2020 - 04/2008
6	Pituitary ACTH Hypersecretion 04/2015 - 09/2009
5	Brain Neoplasms (Brain Tumor) 01/2009 - 10/2003
4	Hypopituitarism (Sheehan's Syndrome) 10/2020 - 12/2013
4	Prolactinoma (Prolactinomas) 01/2015 - 01/2009
4	Glioblastoma (Glioblastoma Multiforme) 01/2011 - 08/2004
3	Hyponatremia 07/2014 - 11/2013
2	Infections 10/2020 - 09/2010
2	Diabetes Insipidus 01/2020 - 07/2014
2	Adenoma (Adenomas) 09/2018 - 07/2013
2	Meningioma (Meningiomas) 06/2014 - 10/2006
2	Neoplasm Metastasis (Metastasis) 01/2009 - 01/2008
1	Surgical Wound Infection 04/2021
1	Leukemia 01/2019
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019
1	Aneuploidy (Aneuploid) 01/2019
1	Medulloblastoma 01/2019
1	Acromegaly 09/2018
1	Growth Hormone-Secreting Pituitary Adenoma 09/2018
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2018
1	Myalgia 01/2018
1	Muscular Diseases (Myopathy) 01/2018
1	Rhabdomyolysis 01/2018
1	Meningitis 07/2014
1	Inappropriate ADH Syndrome (SIADH) 11/2013
1	Residual Neoplasm 05/2011
1	Cysts 09/2010
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 07/2010
1	Aneurysm (Aneurysms) 07/2010
1	Necrosis 01/2009
1	Hyperprolactinemia 01/2009
1	Lymphoma (Lymphomas) 01/2008
1	Central Nervous System Diseases (CNS Diseases) 01/2008
1	Confusion (Bewilderment) 11/2007
1	Aphasia (Dysphasia) 11/2007
1	Brain Injuries (Brain Injury) 10/2006
1	Edema (Dropsy) 10/2006

Drug/Important Bio-Agent (IBA)

6	IL13-PE38IBA 01/2011 - 02/2005
5	Hormones (Hormone)IBA 01/2020 - 10/2004
5	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2015 - 10/2004
4	Pharmaceutical PreparationsIBA 01/2018 - 04/2006
4	ExotoxinsIBA 11/2007 - 10/2003
4	Cytotoxins (Cytolysins)IBA 11/2007 - 02/2005
4	Interleukin-13IBA 11/2007 - 02/2005
3	ProlactinIBA 09/2018 - 01/2009
2	Coloring Agents (Dyes)IBA 09/2018 - 07/2013
2	Growth Hormone (Somatotropin)IBA 09/2018 - 05/2011
2	conivaptan (Vaprisol)FDA Link 12/2013 - 11/2013
2	Vasopressins (Vasopressin)IBA 12/2013 - 11/2013
2	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 01/2011 - 08/2010
2	Biomarkers (Surrogate Marker)IBA 01/2008 - 02/2005
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 04/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	NucleotidesIBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 06/2014
1	Antidiuretic Hormone Receptor AntagonistsIBA 12/2013
1	Tolvaptan FDA Link 12/2013
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 11/2013
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 07/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2010
1	Carmustine (FIVB)FDA Link 08/2010
1	ChromograninsIBA 07/2010
1	SynaptophysinIBA 07/2010
1	Glial Fibrillary Acidic ProteinIBA 07/2010
1	VimentinIBA 07/2010
1	Troleandomycin (TAO)FDA Link 07/2010
1	Iodine-125IBA 01/2009
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2009
1	ErbB Receptors (EGF Receptor)IBA 06/2008
1	Immunotoxins (Immunotoxin)IBA 06/2008
1	RNA (Ribonucleic Acid)IBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	ProteomeIBA 01/2008
1	Temozolomide (Temodar)FDA LinkGeneric 11/2007
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 06/2006
1	CytokinesIBA 06/2006
1	Pseudomonas aeruginosa Exotoxin AIBA 04/2006
1	Biological ProductsIBA 02/2005
1	InterleukinsIBA 02/2005

Therapy/Procedure

13	Radiotherapy 01/2020 - 08/2004
8	Therapeutics 09/2018 - 08/2004
5	Catheters 01/2011 - 02/2005
3	Length of Stay 04/2021 - 07/2014
2	Craniotomy 04/2021 - 10/2006
2	Brachytherapy 01/2009 - 08/2004
2	Operative Surgical Procedures 10/2006 - 04/2006
1	Surgical Decompression 01/2018
1	Drug Therapy (Chemotherapy) 10/2012
1	Surgical Instruments (Clip) 07/2010
1	Laminectomy 07/2010
1	Adjuvant Radiotherapy 04/2008
1	Chemoradiotherapy 11/2007
1	Operative Time 10/2006